Ideal Acquisition Candidates Are Advanced-Stage With Good Data - IN3 Panel
This article was originally published in The Gray Sheet
The most desirable acquisition candidates for established medical technology firms in the current economic climate are those in advanced stages of development with good comparative effectiveness data, according to panelists at the recent Investment In Innovation (IN3) Medical Device Summit
You may also be interested in...
The recession, impending health care reform and the changing regulatory and reimbursement environment are putting pressure on the traditional medtech venture capital funding model, according to a 1report from consulting firm Ernst & Young
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.